Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Advantest Corporation
  6. News
  7. Summary
    6857   JP3122400009

ADVANTEST CORPORATION

(6857)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Japanese shares edge down as tech stocks weigh

06/10/2021 | 11:25pm EDT

TOKYO, June 11 (Reuters) - Japanese shares inched down in seesaw trading on Friday as technology stocks pulled back from early gains, with investors remaining cautious about the pace of domestic economic recovery.

The Nikkei share average inched down 0.06% to 28,939.16 by 0225 GMT, while the broader Topix was down 0.23% to 1,952.24. "Japan's technology stocks are bought as the Nasdaq's gain and the fall in U.S. interest rates lifted investor sentiment," said Jun Morita, general manager of the research department at Chibagin Asset Management.

"But the market was weighed down by uncertainties. It's hard for investors to decide to sell or buy when the Nikkei hovers around the 29,000-level as they are not necessarily optimistic about the Japanese market outlook."

Some market participants say it is still doubtful Japan's economy will recover at the same pace as that in the United States and other advanced nations due to the fourth wave of the pandemic.

Yutaka Miura, a senior technical analyst at Mizuho Securities, said concerns over potential tapering by the Federal Reserve also weighed on investor sentiment.

Airlines declined the most, while financial firms and real estate firms also fell.

Technology firms advanced, with a medical platform M3 Inc rising 2.18%, Advantest gaining 0.48% and Tokyo Electron edging up 0.17%.

Drugmaker Eisai jumped 7% after a sharp fall in the previous session amid a volatile trade this week after U.S. regulators approved of a drug developed by the firm and Biogen for Alzheimer's disease.

Toshiba fell 1.48% after a report from independent investigators said the conglomerate asked the trade ministry to help counter activist investors at its annual general meeting last July. (Reporting by Junko Fujita; Editing by Ramakrishnan M.)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ADVANTEST CORPORATION -1.65% 10110 End-of-day quote.30.79%
BIOGEN INC. -1.99% 383.52 Delayed Quote.56.63%
EISAI CO., LTD. 1.38% 11400 End-of-day quote.54.64%
M3, INC. -3.61% 7338 End-of-day quote.-24.68%
MIURA CO., LTD. -2.61% 4845 End-of-day quote.-15.89%
MORITA HOLDINGS CORPORATION -0.25% 1605 End-of-day quote.-8.49%
NIKKEI 225 -0.19% 28964.08 Real-time Quote.5.74%
TOSHIBA CORPORATION 1.26% 4820 End-of-day quote.67.07%
All news about ADVANTEST CORPORATION
06/17Nikkei tracks Nasdaq's solid finish overnight, Toyota drags Topix
RE
06/16Japanese shares fall on tech selloff as Fed signals earlier rate hikes
RE
06/16Japan's Nikkei ends lower on chip declines, Topix ticks up on Toyota
RE
06/15Nikkei inches down as chip shares track U.S. peers; Toyota lifts Topix
RE
06/11Japanese shares end lower as cyclical stocks drag; Toshiba slips
RE
06/10Japanese shares edge down as tech stocks weigh
RE
05/31Japanese shares end lower on profit-booking, drugmakers limit losses
RE
05/30Japanese shares retreat from 3-week high; drugmakers limit losses
RE
05/25Japanese shares end higher on Wall Street gains, slow growth concerns weigh
RE
05/24Japanese shares rise on tech boost, economic recovery worries cap gains
RE
More news
Financials
Sales 2021 305 B 2 771 M 2 771 M
Net income 2021 60 000 M 545 M 545 M
Net cash 2021 148 B 1 340 M 1 340 M
P/E ratio 2021 33,7x
Yield 2021 0,91%
Capitalization 1 986 B 18 002 M 18 028 M
EV / Sales 2021 6,02x
EV / Sales 2022 4,98x
Nbr of Employees 4 494
Free-Float 95,6%
Chart ADVANTEST CORPORATION
Duration : Period :
Advantest Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADVANTEST CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 10 896,82 JPY
Last Close Price 10 110,00 JPY
Spread / Highest target 28,6%
Spread / Average Target 7,78%
Spread / Lowest Target -61,5%
EPS Revisions
Managers and Directors
NameTitle
Yoshiaki Yoshida Executive President, CEO & Representative Director
Hans-Juergen Wagner Director & Head-Test Technology
Kazuhiro Yamashita General Manager-Technology Development
Atsushi Fujita Director & Head-Administration
Osamu Karatsu Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
ADVANTEST CORPORATION30.79%18 002
KLA CORPORATION22.98%48 808
TERADYNE, INC.8.09%21 546
LASERTEC CORPORATION78.94%17 714
TONGFU MICROELECTRONICS CO.,LTD-12.84%4 514
HANGZHOU CHANGCHUAN TECHNOLOGY CO.,LTD92.50%2 822